Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (25)

• A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
• Anatomical distribution of deeply infiltrating endometriosis: surgical implications and proposition for a classification via openalex
• Association rate between deep peritoneal endometriosis and other forms of the disease: pathogenetic implications via openalex
• Comparison of complete and incomplete excision of deep infiltrating endometriosis. via openalex
• Comparison of Complete and Incomplete Excision of Deep Infiltrating Endometriosis via openalex
• Determinants of long-term clinically detected recurrence rates of deep, ovarian, and pelvic endometriosis via openalex
• Dienogest: A New Therapeutic Agent for the Treatment of Endometriosis via openalex
• Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic stromal cells in spheroid culture via openalex
• Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex
• Endometriosis: What is the risk of hospital admission, readmission, and major surgical intervention? via openalex
• Long-Term Administration of Dienogest Reduces Recurrence after Excision of Endometrioma via openalex
• Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex
• Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy via openalex
• Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial via openalex
• Medical treatment for rectovaginal endometriosis: what is the evidence? via openalex
• Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis via openalex
• Surgery versus hormonal therapy for deep endometriosis: is it a choice of the physician? via openalex
• W6714496033 via openalex
• W2024158781 via openalex
• W2079421112 via openalex
• W2100503022 via openalex
• W2126339803 via openalex
• W2130203785 via openalex
• W2163315477 via openalex
• W1516382093 via openalex

Cited by (23)

• Efficacy and safety of dienogest in the treatment of deep infiltrating endometriosis: A meta-analysis 2024
• Dienogest therapy: a window of opportunity for endometriosis 2023
• The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery: a Systematic Review and Meta-Analysis 2023
• Evaluation of long-term efficacy and safety of dienogest in patients with chronic cyclic pelvic pain associated with endometriosis 2023
• Progesterone receptor ligands for the treatment of endometriosis 2022
• Cost-effectiveness Analysis of Dienogest Compared with Combined Oral Contraceptives after Surgery for Endometriosis 2022
• Application of Dienogest In the Treatment of Endometriosis 2022
• Efficacy of Dienogest for Prevention of Endometriosis Recurrence: A Systematic Review and Meta-Analysis 2022
• Dienogest as a Maintenance Treatment for Endometriosis Following Surgery: A Systematic Review and Meta-Analysis 2021
• Patient-reported utilization patterns of endometriosis medications in Europe: Real-world results from the non-interventional VIPOS study 2021
• Endometriosis, hormonal therapy and oncological risks 2021
• Clinical and diagnostic aspects of deep infiltrative endometriosis (diagnosis, treatment, recurrence) 2021
• Gestagenes in the treatment of endometriosis: efficiency, safety, bioequivalence, transferability 2021
• Hormonresistenz in der medikamentösen Therapie der Endometriose 2020
• Dienogest and the Risk of Endometriosis Recurrence Following Surgery: A Systematic Review and Meta-analysis 2020
• Use of dienogest in endometriosis: a narrative literature review and expert commentary 2020
• Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery 2019
• Is Long-Term Dienogest Treatment Tolerable in Korea? 2019
• Clinical studies investigating the use of leuprorelin in Asian women with endometriosis: a review 2019
• Reviewing the role of progesterone therapy in endometriosis 2018
• Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis 2018
• Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice 2018
• Dienogest in the Treatment of Endometriosis 2017

Source provenance

europepmc

last seen: 2026-06-11T06:19:48.454388+00:00

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

pubmed

last seen: 2026-05-13T22:20:19.560968+00:00

unpaywall

last seen: 2026-06-05T02:00:03.366016+00:00